<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">
    <title>Medical Mastermind V6.3 (Final)</title>
    <style>
        :root { --bg: #1e1e2e; --surface: #313244; --surface-2: #45475a; --text: #cdd6f4; --primary: #89b4fa; --success: #a6e3a1; --danger: #f38ba8; --accent: #fab387; --cat-badge: #cba6f7; }
        body { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; background-color: var(--bg); color: var(--text); display: flex; flex-direction: column; align-items: center; min-height: 100vh; margin: 0; padding: 15px; box-sizing: border-box; }
        .container { background: var(--surface); padding: 1.5rem; border-radius: 16px; box-shadow: 0 10px 30px rgba(0,0,0,0.4); max-width: 800px; width: 100%; text-align: center; position: relative; display: flex; flex-direction: column; gap: 15px; }
        h1 { margin: 0; color: var(--primary); font-size: 1.8rem; letter-spacing: -0.5px; }
        .stats-bar { display: flex; justify-content: space-between; font-size: 0.85rem; color: #a6adc8; font-weight: 500; padding: 0 5px; }
        .nav-scroll-wrapper { overflow-x: auto; padding-bottom: 5px; margin: 0 -10px; -webkit-overflow-scrolling: touch; }
        .nav-bar { display: flex; gap: 8px; padding: 0 10px; min-width: min-content; }
        .nav-btn { white-space: nowrap; padding: 8px 16px; border: none; background: var(--surface-2); color: #bac2de; border-radius: 20px; font-weight: 600; font-size: 0.85rem; cursor: pointer; transition: all 0.2s ease; }
        .nav-btn.active { background: var(--primary); color: var(--bg); box-shadow: 0 4px 12px rgba(137, 180, 250, 0.3); }
        .nav-btn.flagged-deck.active { background: var(--danger); color: var(--bg); box-shadow: 0 4px 12px rgba(243, 139, 168, 0.3); }
        .question-card { background: #181825; padding: 25px; border-radius: 12px; border: 1px solid var(--surface-2); position: relative; min-height: 220px; display: flex; flex-direction: column; justify-content: center; }
        .flag-toggle { position: absolute; top: 12px; right: 12px; background: transparent; border: none; color: var(--surface-2); font-size: 1.5rem; cursor: pointer; transition: transform 0.2s; }
        .flag-toggle.active { color: var(--danger); }
        
        .class-card-header { color: var(--cat-badge); font-size: 0.9rem; text-transform: uppercase; font-weight: 800; letter-spacing: 1px; margin-bottom: 15px; display: block; border-bottom: 1px solid var(--surface-2); padding-bottom: 10px; }
        
        .vignette-container { text-align: left; display: flex; flex-direction: column; gap: 12px; }
        .vignette-item { border-left: 3px solid var(--accent); padding-left: 12px; }
        .vignette-label { display: block; color: var(--accent); font-size: 0.75rem; text-transform: uppercase; font-weight: 700; letter-spacing: 0.5px; margin-bottom: 4px; }
        .vignette-text { font-size: 1.05rem; line-height: 1.5; color: #e6e9ef; }
        
        .drug-list { list-style: none; padding: 0; margin: 0; text-align: center; font-weight: 600; color: #cdd6f4; font-size: 1.2rem; line-height: 1.8; }
        .drug-list li { margin-bottom: 8px; border-bottom: 1px dashed var(--surface-2); padding-bottom: 8px; }
        .drug-list li:last-child { border-bottom: none; }

        .controls { display: flex; justify-content: center; align-items: center; gap: 15px; margin-bottom: 5px; background: rgba(0,0,0,0.2); padding: 8px; border-radius: 12px; }
        .switch-label { display: flex; align-items: center; gap: 10px; cursor: pointer; font-size: 0.9rem; font-weight: 600; }
        .toggle-switch { position: relative; width: 44px; height: 24px; background: var(--surface-2); border-radius: 12px; transition: 0.3s; }
        .toggle-switch::after { content: ''; position: absolute; top: 2px; left: 2px; width: 20px; height: 20px; background: white; border-radius: 50%; transition: 0.3s; box-shadow: 0 2px 4px rgba(0,0,0,0.2); }
        input:checked + .toggle-switch { background: var(--primary); }
        input:checked + .toggle-switch::after { transform: translateX(20px); }
        .options-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 12px; }
        @media (max-width: 600px) { .options-grid { grid-template-columns: 1fr; } }
        .opt-btn { background: var(--surface-2); border: none; padding: 16px; border-radius: 10px; color: white; font-size: 0.95rem; font-weight: 500; cursor: pointer; transition: transform 0.1s, background 0.2s; min-height: 60px; display: flex; align-items: center; justify-content: center; text-align: center; line-height: 1.3; word-break: break-word; }
        .opt-btn.correct { background: var(--success); color: var(--bg); box-shadow: 0 0 15px rgba(166, 227, 161, 0.4); border: 1px solid var(--success); }
        .opt-btn.wrong { background: var(--danger); color: var(--bg); opacity: 0.6; }
        .flashcard-area { display: flex; flex-direction: column; gap: 15px; }
        .reveal-btn { width: 100%; background: var(--accent); color: var(--bg); font-weight: 800; padding: 20px; border: none; border-radius: 12px; font-size: 1.1rem; cursor: pointer; letter-spacing: 0.5px; }
        .answer-reveal { background: var(--surface-2); padding: 20px; border-radius: 12px; border: 2px solid var(--success); color: var(--success); font-weight: bold; font-size: 1.3rem; text-align: center; }
        .next-btn { background: var(--primary); color: var(--bg); width: 100%; padding: 18px; border: none; border-radius: 12px; font-weight: 800; font-size: 1.1rem; cursor: pointer; margin-top: 10px; box-shadow: 0 4px 15px rgba(137, 180, 250, 0.4); }
        .hidden { display: none !important; }
    </style>
</head>
<body>

<div class="container">
    <h1>Medical Mastermind</h1>
    <div class="stats-bar">
        <span id="deck-indicator">Deck: Loading...</span>
        <span id="streak-indicator">Streak: 0</span>
        <span id="remaining-indicator">Cards: 0</span>
    </div>
    <div class="nav-scroll-wrapper"><div id="nav-container" class="nav-bar"></div></div>
    <div class="controls">
        <label class="switch-label">
            <input type="checkbox" id="mode-switch" onchange="toggleMode()" style="display:none">
            <div class="toggle-switch"></div>
            <span id="mode-label">Mode: Quiz</span>
        </label>
    </div>
    <div class="question-card">
        <button id="flag-btn" class="flag-toggle" onclick="toggleFlag()" title="Flag for Review">★</button>
        <div id="vignette-box" class="vignette-container"></div>
    </div>
    <div id="quiz-area" class="options-grid"></div>
    <div id="flashcard-area" class="flashcard-area hidden">
        <button id="reveal-btn" class="reveal-btn" onclick="revealFlashcard()">REVEAL ANSWER</button>
        <div id="flashcard-answer" class="answer-reveal hidden"></div>
        <div id="flashcard-judgement" class="options-grid hidden">
            <button class="opt-btn wrong" onclick="rateFlashcard(false)">Forgot</button>
            <button class="opt-btn correct" onclick="rateFlashcard(true)">Remembered</button>
        </div>
    </div>
    <button id="next-btn" class="next-btn hidden" onclick="nextQuestion()">Next Card ➔</button>
</div>

<script>
// --- DATABASE ---
const db = {
  "Anti-Neoplastics": [{"name":"Methotrexate","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Folic Acid Analog","Mechanism of Action":"Folic acid analog, inhibits dihydrofolate reductase","Use":"ALL, non-Hodgkin's lymphomas, osteosarcomas, soft tissue sarcomas, carcinomas of head, neck & bladder\n\nBreast cancer in post-menopausal women with no estrogen receptors\n\nLow dose effective for RA and psoriasis","Curative":"Curative at high doses for osteogenic sarcomas and choriocarcinomas","Toxicity":"myelosuppression, GI toxicity (reversed with leucovorin)\n\nHepatotoxicity at high doses (helps to hydrate pts), nephrotoxicity, pulmonary toxicity, dermatologic rxns, death (?!)"}},{"name":"Leucovorin","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Folate Antagonist Rescue Agent","Mechanism of Action":"Bypasses blocked DHFR, therefore bypassing metabolic block of MTX","Use":"Inihibiting methotrexate toxicity","Mnemonic":"Luke to the rescue!"}},{"name":"6-Mercaptopurine","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Purine Analog","Mechanism of Action":"inhibits purine biosynthesis","Use":"maintenance of remission in ALL","Toxicity":"Myelosuppression\n\nHyperuricemia, if allopurinol is used to treat, must lower 6-MP dose","Other Notes":"1/300 pts have mutation that blocks metabolism of 6-MP, can cause fatal accumulation\n\nGenetic testing is done prior to giving drug","Mnemonic":"MP (military police) control ALL"}},{"name":"6-Thioguanine","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Purine Analog","Mechanism of Action":"pseudo-feedback inhibitor of phosphoribosyl pyrophosphate aminotransferase, thus inhibiting purine biosynthesis","Use":"Acute granulocytic leukemia with cytrabine (AraC) and daunorubicin","Toxicity":"Myelosuppression"}},{"name":"5-Fluorouracil","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Pyrimidine Analog","Mechanism of Action":"Competitively inhibits thymidylate synthase leading to a decrease in DNA synthesis and cell death","Use":"Slow growing solid tumors, breast cancer, colon & rectum cancers, basal cell carcinomas, pancreatic cancer","Toxicity":"myelosuppression, GI toxicity","Other Notes":"Taking it with cimetidine (OTC heartburn med) there is a higher rate of survival\n\nCisplatin, \nLeucovorin, methotrexate enhance activity","Mnemonic":"MP (military police) control ALL"}},{"name":"Capecitabine","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Pyrimidine Analog"}},{"name":"Cytarabine (AraC)","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Pyrimidine Analog","Mechanism of Action":"incorporates into DNA and terminates chain elongation","Use":"AML with 6-TG, lymphomas, neoplastic meningitis","Toxicity":"severe myelosuppression, high doses can cause acute cerebellar syndrome (10-25% of pts)"}},{"name":"Gemcitabine (dFdC)","attributes":{"Class":"Antimetabolites (S phase)","Subclass":"Pyrimidine Analog","Mechanism of Action":"inhibits DNA polymerase","Use":"1st line for metastatic pancreatic, bladder, and non-small cell lung cancer\n\nCan also be used for metastatic breast, cervical, head and neck cancers, lymphomas","Toxicity":"myelosuppression, flu-like syndrome, mild elevation of liver transamination"}},{"name":"Vinblastine","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Vinca Alkaloids (M-phase)","Mechanism of Action":"reversibly bind tubulin and block polymerization into microtubules","Use":"Childhood ALL, Hodgkins, AML, non-Hodgkins, pediatric solid tumors, some adult solid tumors (breast, lung, cervix)","Toxicity":"bone marrow suppression","Mnemonic":"Bone marrow suppression"}},{"name":"Vincristine","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Vinca Alkaloids (M-phase)","Use":"Lymphomas, choriocarcinoma","Curative":"metastatic testicular tumors with Bleomycin & Cisplatin","Toxicity":"peripheral neuropathy","Mnemonic":"Jesus probably had neuropathy \non the cross"}},{"name":"Paclitaxel","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Taxanes (M-phase)","Mechanism of Action":"Promotes microtubule formation and stabilization","Use":"Metastatic ovarian and breast cancer","Toxicity":"hypersensitivity, myelosuppression, neuropathy","Other Notes":"Premedicate with dexamethasone, diphenhydramine, H2 blockers"}},{"name":"Docetaxel","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Taxanes (M-phase)"}},{"name":"Etoposide","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Podophyllotoxins (S/G2-phase)","Mechanism of Action":"inhibits topoisomerase II, thus blocking DNA replication","Use":"Testicular tumors in combination with bleomycin & cisplatin, small cell carcinoma of the lung with cisplatin & ifosfamide","Toxicity":"myelosuppression, alopecia","Mnemonic":"Etoposide --> topoisomerase"}},{"name":"Topotecan","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Camptothecins","Mechanism of Action":"inhibits regulation of single-stranded breaks, topoisomerase I","Use":"previously treated metastatic ovarian and advanced small-cell lung cancer"}},{"name":"Irinotecan","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"Camptothecins","Use":"metastatic colorectal cancer that has returned or progressed after 5-FU treatment, pancreatic cancer","Toxicity":"diarrhea, myelosuppression, alopecia, nausea, vomiting, cholinergic symptoms, mucositis, bronzing of skin","Other Notes":"10% of pts homozygous for UGT1A1 have increased chance of severely low WBCs"}},{"name":"Bleomycin","attributes":{"Class":"Natural Products: Phase Specific","Subclass":"G2-phase","Mechanism of Action":"binds DNA, generates free radicals and strand \nbreaks, inhibits DNA ligase (DNA repair), cells accumulate in G2","Use":"part of combination therapy for testicular carcinomas with cisplatin and vinblastine/etoposide\n\nsquamous carcinomas, lymphomas","Curative":"metastatic testicular tumors with Vincristine & Cisplatin","Toxicity":"pneumonitis, pulmonary fibrosis, hyperpigmentation, stomatitis, alopecia","Other Notes":"One of the least myelosuppressive drugs"}},{"name":"Actinomycin D","attributes":{"Class":"Natural Products: DNA-binding Antibiotics","Subclass":"Actinomycin D","Mechanism of Action":"Intercalates in DNA --> inhibits DNA/RNA synthesis","Use":"Wilm's tumor, rhabdomyosarcoma (pediatric tumors)\n\nmethotrexate-resistant gestational choriocarcinoma, ewing's sarcoma","Curative":"Wilm's tumor with Vincristine & Cyclophosphamide after surgery and radiotherapy","Toxicity":"myelosuppression"}},{"name":"Doxorubicin (Adriamycin)","attributes":{"Class":"Natural Products: DNA-binding Antibiotics","Subclass":"Anthracyclines","Use":"myelomas, sarcomas, lymphomas","Toxicity":"Cardiomyopathy (epirubicin less so)\n\nmyelosuppression, severe alopecia","Other Notes":"mutagenic and carcinogenic"}},{"name":"Daunorubicin","attributes":{"Class":"Natural Products: DNA-binding Antibiotics","Subclass":"Anthracyclines","Use":"acute leukemias"}},{"name":"Epirubicin","attributes":{"Class":"Natural Products: DNA-binding Antibiotics","Subclass":"Anthracyclines","Use":"adjuvent therapy for breast cancer, esp.\npre-menopausal node positive women"}},{"name":"Hydroxyurea","attributes":{"Class":"Miscellaneous","Subclass":"Hydroxyurea","Mechanism of Action":"inhibits ribonucleoside diphosphate reductase","Use":"sometimes for leukemias, imatinib mesylate more often used today","Toxicity":"myelosuppression, may be carcinogenic"}},{"name":"L-asparagine","attributes":{"Class":"Miscellaneous","Subclass":"L-asparagine","Mechanism of Action":"cells have no or low levels of asparagine synthetase activity","Use":"ALL w/ vincristine & prednisone","Toxicity":"hypersensitivity from antigenicity (polypeptide of bacterial origin)\nVenous thrombosis"}},{"name":"Thalidomide","attributes":{"Class":"Miscellaneous","Subclass":"Thalidomide","Mechanism of Action":"bind to cereblon activating an enzyme, stimualtes T and NK cells, inhibits angiogenesis","Use":"multiple myeloma","Toxicity":"sedation, constipation, peripheral neuropathy, venous thromboembolism","Other Notes":"DO NOT GIVE TO PREGNANT WOMEN\n\nMutagenic, teratogenic"}},{"name":"Vorinostat","attributes":{"Class":"Miscellaneous","Subclass":"Vorinostat","Mechanism of Action":"histone deacetylase inhibitor, increases transcriptional activation, cell cycle arrest, differentiation, and apoptosis","Use":"Cutaneous T-cell lymphomas that are persistent, progressive, or recurrent after systemic therapy","Toxicity":"fatigue, diarrhea, nausea, anorexia, weight loss, thrombocytopenia, pulmonary embolism, squamous cell carcinomas"}},{"name":"Bortezomib","attributes":{"Class":"Proteasome Inhibitor","Subclass":"Proteasome Inhibitor","Mechanism of Action":"inhibits 26S proteosome","Use":"1st line for \nmultiple myeloma and relapsed/refractory multiple myeloma","Toxicity":"nausea, diarrhea, muscle weakness, myelosuppression, peripheral neuropathy, fever, anorexia, anemia, constipation"}},{"name":"Imatinib mesylate (GLEEVEC)","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Mechanism of Action":"binds to Bcr-Abl kinase and blocks activity","Use":"CML\n\nchemotherapy-resistant GI stromal sarcoma, relapsed/refractory ALL","Toxicity":"nausea, edema, muscle cramps, rash, diarrhea, bone marrow suppression","Other Notes":"can increase certain drug serum concentrations"}},{"name":"Erlotinib","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Mechanism of Action":"inhibits EGFR tyrosine kinase","Use":"non-small cell lung cancer in pts with EGFR mutation that make them resistant to traditional chemo"}},{"name":"Gefitinib (IRESSA)","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Toxicity":"well-tolerated, diarrhea and acne-like rash","Other Notes":"inducers of P450 decrease serum concentrations\n\nworks best in pts who have never smoked of Asian origin"}},{"name":"Lapatinib","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Mechanism of Action":"inhibits EGFR, HER2","Use":"Her2+ breast cancer"}},{"name":"Sunitinib","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Mechanism of Action":"inhibits VEGFR, PDGFR","Use":"renal cell carcinoma, GI stromal tumors"}},{"name":"Sorafenib","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Mechanism of Action":"inhibits cell surface and intracellular kinases","Use":"kidney \nand liver cancer"}},{"name":"Vemurafenib","attributes":{"Class":"Protein Tyrosine Kinase Inhibitors (-ib)","Subclass":"Protein Tyrosine Kinase Inhibitors (-ib)","Mechanism of Action":"inhibits BRAF","Use":"malignant melanoma"}},{"name":"Trastuzumab (Herceptin)","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"binds HER2/neu receptor","Use":"Her2+ breast cancer\n\nbeing tested in ovarian and gastric tumors","Toxicity":"very few, fever and chills, cardiac when given with adriamycin"}},{"name":"Rituximab (Rituxan)","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"binds CD20 receptor","Use":"low grade B-cell Non-Hodgkins lymphoma","Toxicity":"fever, chills, nausea on first infusion"}},{"name":"Cetuximab (Erbitux)","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"Binds EGFR","Use":"colon cancer, being tested for others","Toxicity":"acne-like skin rash"}},{"name":"Bevacizumab (Avastin)","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"Binds VEGF","Use":"metastatic colorectal cancer with 5-FU and leucovorin\n\nNOT recommended for breast cancer","Toxicity":"abdominal pain, nausea, constipation, GI bleeding, ulcers, severe hypertension, severe bleeding, impaired wound healing, heart attack/failure"}},{"name":"Panitumumab (Vectibix)","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"Binds EGFR"}},{"name":"Ipilimumab","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"checkpoint inhibitor: binds CTLA-4","Use":"work only on a subset of pts with lung cancers, renal cancers, lymphomas, melanomas"}},{"name":"Nivolumab","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"checkpoint inhibitor: binds PD-1"}},{"name":"Pembrolizumab","attributes":{"Class":"Monoclonal Antibodies (-mab)","Subclass":"Monoclonal Antibodies (-mab)","Mechanism of Action":"checkpoint inhibitor: binds PD-1"}},{"name":"CTL019, \nTisagenlecleucel ","attributes":{"Class":"CAR-T Therapy","Subclass":"CAR-T Therapy","Mechanism of Action":"T cells from pts are altered to recognize CD19","Use":"relapsed/refractory ALL, some B cell lymphomas","Toxicity":"cytokine release syndrome (flu-like symptoms, respiratory distress, neuro toxicities)"}},{"name":"Interferon-alfa","attributes":{"Class":"Biological Response Modifiers","Subclass":"Biological Response Modifiers","Use":"hairy cell lymphoma, kaposi's sarcoma, malignant melanoma","Toxicity":"fever/chills, myelosuppression, neurotoxicity"}},{"name":"Interleukin-2","attributes":{"Class":"Biological Response Modifiers","Subclass":"Biological Response Modifiers","Mechanism of Action":"induces T cell response cytolytic for tumor cells","Use":"advanced malignant melanoma and renal cell cancer","Toxicity":"capillary leak syndrome, arrythmias, elevated liver function, anemia, thrombocytopenia, nausea, diarrhea, fever"}},{"name":"G-CSF, Filgrastim","attributes":{"Class":"Biological Response Modifiers","Subclass":"Biological Response Modifiers","Mechanism of Action":"expands neutrophil granulocyte precursor population, augments granulocyte function","Use":"prophylaxis of chemo-induced neutropenia","Toxicity":"bone pain in lower back, sternum and pelvis"}},{"name":"Prednisone","attributes":{"Class":"Biological Response Modifiers","Subclass":"Biological Response Modifiers","Mechanism of Action":"inihibits inflammatory response","Use":"a part of many cancer drug regimens \n\nautoimmune diseases: RA, MS\nbrain swelling, asthma, severe allergic rxns","Toxicity":"increased infections, hyperglycemia, diabetes, osteoporosis, adrenal suppression, hypertension, heart/kidney \nfailure"}}],
  "WBC Disorders": [{"name":"Lymphopenia","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"HIV, glucocorticoids, cytotoxic drugs, autoimmune disease, acute viral infection, malnutrition"}},{"name":"Neutropenia","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"1. Ineffective granulopoieses: aplastic anemia, infiltration of marrow by granulomas, tumor, drugs, megaloblastic anemias, MDS, Kostmann Syndrome (rare)\n\n2. Increased destruction: Immune (autoimmune, drug related), overwhelming infection\n\n3. Sequestration: Splenomegaly","Symptoms/signs":"Malaise, fever, chills, weakness, fatigue","Treatment":"Broad spectrum antibiotics, G-CSF after chemo"}},{"name":"Agranulocytosis (extreme neutropenia)","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"Drug toxicity (alkylating agents and antimetabolites)\n\nIdiosyncratic reaction to agents (chloramphenicol, sulfonamides, chlorpromazine, thiouracil, phenylbutazone)"}},{"name":"Neutrophilia","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"acute bacterial infections, especially by pyogenic organisms, sterile inflammation caused by tissue necrosis (MI, burns)"}},{"name":"Eosinophilia","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"Allergic disorders such as asthma, hay fever, parasitic infestations, drug reactions, certain malignancies (e.g. lymphomas), autoimmune disorders (pemphigus, dermatitis herpetiformis), vasculitides, atheroembolic disease (transient)"}},{"name":"Basophilia","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"rare, often indicative of myeloproliferative neoplasm (CML, etc.)"}},{"name":"Monocytosis","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"Chronic infections (e.g. TB), bacterial endocarditis, rickettsiosis, malaria, autoimmune (e.g. SLE), IBD (e.g. ulcerative colitis)"}},{"name":"Lymphocytosis","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"accompanies monocytosis in many disorders associated with chronic immunologic stimulation (e.g. TB, brucellosis)\n\nviral infections (Hep A, CMV, EBV)\n\nBordetella pertussis"}},{"name":"Reactive PMNs","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"seen in severe infection or tissue necrosis","Morphological changes":"Toxic granulations (darker than normal, coarse)\nDoyle bodies (patches of dilated endoplasmic reticulum, look like blue clouds)\nCytoplasmic vacuoles (phagolysosomes, indicate phagocytosis)"}},{"name":"Acute Nonspecific Lymphadenitis","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"direct microbiologic drainage (usually focal) or systemic infection (usually generalized)","Symptoms/signs":"swollen, gray-red and engorged nodes\n\npainful because rapid expansion of node stretches the capsule"}},{"name":"Chronic Nonspecific Lymphadenitis","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"Follicular hyperplasia: seen in infections or inflammations that activate B-cells (RA, toxoplasmosis, early HIV)\n\nParacortical hyperplasia: seen in infections or inflammations that activate T-cells (viral infections, vaccinations, drugs like phenytoin)\n\nSinus histiocytosis: distension and prominence of the lymphatic sinusoids, often seen in lymph nodes draining cancers (breast)","Symptoms/signs":"non-tender lymph nodes because slow expansion does not stretch capsule"}},{"name":"Ebstein-Barr Virus","attributes":{"Class":"Benign Disorders","Cause(s)/pathophysiology":"Infectious Mononucleosis\n\nself limited lymphoproliferative disorder caused by EBV (a B-lymphotrophic herpesvirus)","Symptoms/signs":"fever, sore throat, generalized lymphadenitis, lymphocytosis of CD8+ T cells","Morphological changes":"Atypical lymphocytes (Downey cells): enlarged nucleus, abundant flowing cytoplasm that can indent by surrounding RBCs","Treatment":"supportive"}},{"name":"Follicular Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Older adults","Symptoms/signs":"Generalized lymphadenopathy\n\nLess common to have extranodal sites","Immunophenotype & Translocation":"t(14;18) -> overexpression of BCL-2\n\nBCL-2 antagonizes apoptosis and promotes survival of follicular lymphoma cells","Histology":"Nodular growth pattern","Prognosis":"Indolent course, but incurable\n\n40% progress to diffuse large B-cell lymphoma"}},{"name":"Diffuse Large B-Cell Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Adults (median age 60), can occur in children","Symptoms/signs":"Rapidly enlarging mass at a nodal or extranodal site (GI tract, brain)\n\nWaldeyer ring (oropharyngeal lymphoid tissue involved)","Immunophenotype & Translocation":"Dysregulation of BCL-6 (DNA binding zinc finger transcription repressor) is common (30%)\n\nt(14;18) in 10-20% of cases","Histology":"Diffuse growth pattern\nCells are large (4-5x size of lymphocyte)","Prognosis":"Aggressive, rapidly fatal without treatment\n\nWith intensive combination chemo, 60-80% achieve remission and 50% are cured"}},{"name":"Burkitts Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Children or young adults (30% of childhood NHLs)","Symptoms/signs":"Endemic (African): Mandible/maxilla mass\nSporadic (North American): Abdominal mass","Morphological changes":"Starry sky appearance (macrophages ingesting apoptotic cells)","Immunophenotype & Translocation":"Translocations of c-MYC on chromosome 8\nt(8;14) is most common -> c-MYC overexpression","Prognosis":"Very aggressive, but potentially curable with intensive chemotherapy"}},{"name":"Mantle Cell Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Older men","Symptoms/signs":"Generalized lymphadenopathy\n\nSpleen, liver, bone marrow, and GI tract involvement common","Immunophenotype & Translocation":"t(11;14) -> Cyclin D1 overexpression (promotes G1 to S phase progression)\n\nCD5 positive","Prognosis":"Poor prognosis (median survival 3-4 years), not curable with conventional therapy"}},{"name":"Marginal Zone Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Cause(s)/pathophysiology":"Often arise in tissues involved by chronic inflammation (autoimmune or infectious)\n\nSalivary glands in Sjogren disease, Thyroid in Hashimoto thyroiditis, Stomach in H. pylori gastritis","Typical Population":"Adults","Symptoms/signs":"MALToma (Mucosa Associated Lymphoid Tissue)","Prognosis":"Indolent course\n\nMay regress if inciting agent (e.g. H. pylori) is eradicated"}},{"name":"Lymphoplasmacytic Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Symptoms/signs":"Waldenstrom Macroglobulinemia (Hyperviscosity syndrome due to IgM)\n\nVisual impairment, neurological problems, bleeding, cryoglobulinemia","Labs":"Monoclonal IgM spike on SPEP","Prognosis":"Indolent course, incurable"}},{"name":"Adult T-cell Leukemia/Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Cause(s)/pathophysiology":"Caused by HTLV-1 (Human T-cell Leukemia Virus Type 1)","Typical Population":"Adults in endemic areas (Japan, West Africa, Caribbean)","Symptoms/signs":"Skin lesions, generalized lymphadenopathy, hepatosplenomegaly, lytic bone lesions, hypercalcemia","Prognosis":"Fatal within months to one year"}},{"name":"Mycosis Fungoides","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Adults","Symptoms/signs":"Cutaneous patches, plaques, and tumors (CD4+ T cells home to skin)","Morphological changes":"Pautrier microabscesses (aggregates of neoplastic cells in epidermis)","Prognosis":"Indolent course, but can progress to Sezary syndrome"}},{"name":"Sezary Syndrome","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Adults","Symptoms/signs":"Leukemic phase of Mycosis Fungoides\n\nGeneralized erythroderma (red skin)","Morphological changes":"Cerebriform nuclei (Sezary cells) in blood","Prognosis":"Poor prognosis"}},{"name":"Extranodal NK/T-cell Lymphoma","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Cause(s)/pathophysiology":"Strongly associated with EBV","Typical Population":"Adults (more common in Asia)","Symptoms/signs":"Nasopharyngeal mass, destructive midline facial lesions","Prognosis":"Aggressive, poor prognosis"}},{"name":"Nodular sclerosis","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Young adults (especially women)","Symptoms/signs":"Mediastinal mass","Morphological changes":"Lacunar cells (RS cell variant), bands of collagen separating nodules","Prognosis":"Excellent prognosis"}},{"name":"Mixed Cellularity","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Older men","Symptoms/signs":"Abundant eosinophils (recruited by IL-5 from RS cells)","Prognosis":"Good prognosis"}},{"name":"Lymphocyte Rich","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Uncommon","Prognosis":"Excellent prognosis"}},{"name":"Lymphocyte Depletion","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Elderly, HIV+ individuals","Prognosis":"Poor prognosis"}},{"name":"Nodular Lymphocyte Predominance","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Young men (<35)","Morphological changes":"Popcorn cells (L&H cells - Lymphocytic and Histiocytic)","Immunophenotype & Translocation":"CD20+, CD45+ (Different from Classic Hodgkin which is CD15+, CD30+)","Prognosis":"Excellent prognosis"}},{"name":"B-ALL","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Children (most common childhood malignancy)","Immunophenotype & Translocation":"t(12;21) -> good prognosis\nt(9;22) -> poor prognosis (more common in adults)","Prognosis":"Good (80% cure rate in children)"}},{"name":"T-ALL","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Adolescent males","Symptoms/signs":"Mediastinal mass (Thymic mass) -> SVC syndrome","Prognosis":"Good"}},{"name":"AML","attributes":{"Class":"Myeloid Neoplasms","Typical Population":"Older adults (median age 65)","Morphological changes":"Auer rods (crystal aggregates of MPO), >20% blasts in marrow","Prognosis":"Poor prognosis (15-70% depending on subtype)"}},{"name":"APL (M3)","attributes":{"Class":"Myeloid Neoplasms","Cause(s)/pathophysiology":"t(15;17) PML-RARA fusion","Treatment":"ATRA (All-trans retinoic acid) causes differentiation","Complications":"High risk of DIC"}},{"name":"CLL","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Elderly (most common leukemia in adults)","Morphological changes":"Smudge cells (fragile lymphocytes)","Immunophenotype & Translocation":"CD5+, CD20+","Prognosis":"Indolent, long survival"}},{"name":"CML","attributes":{"Class":"Myeloid Neoplasms","Cause(s)/pathophysiology":"t(9;22) BCR-ABL (Philadelphia chromosome)","Treatment":"Imatinib (Tyrosine kinase inhibitor)"}},{"name":"Hairy Cell Leukemia","attributes":{"Class":"Lymphoid Neoplasms (WHO Classification)","Typical Population":"Middle aged men","Symptoms/signs":"Massive splenomegaly, no lymphadenopathy, Dry tap (marrow fibrosis)","Morphological changes":"Hairy projections on lymphocytes","Treatment":"Cladribine (2-CDA)"}},{"name":"Multiple Myeloma","attributes":{"Class":"Plasma Cell Disorders","Typical Population":"Elderly (median age 70)","Symptoms/signs":"CRAB (Hypercalcemia, Renal failure, Anemia, Bone lytic lesions/Back pain)","Morphological changes":"Rouleaux formation of RBCs","Labs":"M-spike (IgG or IgA), Bence Jones protein (light chains in urine)"}},{"name":"Waldenstrom macroglobulinemia","attributes":{"Class":"Plasma Cell Disorders","Typical Population":"Elderly","Symptoms/signs":"Hyperviscosity (blurred vision, Raynaud phenomenon), bleeding","Labs":"M-spike (IgM)"}},{"name":"Primary or Imunocyte-associated amyloidosis","attributes":{"Class":"Plasma Cell Disorders","Cause(s)/pathophysiology":"AL amyloid (Light chains) deposition","Symptoms/signs":"Nephrotic syndrome, Restrictive cardiomyopathy, Macroglossia","Treatment":"Imatinib"}},{"name":"Monoclonal gammopathy of undetermined significance (MGUS)","attributes":{"Class":"Plasma Cell Disorders","Definition":"M-spike <3g/dL, No CRAB symptoms","Prognosis":"1% risk of progression to Multiple Myeloma per year"}},{"name":"Myelodysplastic Syndrome","attributes":{"Class":"Myeloid Neoplasms","Cause(s)/pathophysiology":"Ineffective hematopoiesis, defects in cell maturation","Risk":"Progression to AML"}},{"name":"Polycythemia Vera","attributes":{"Class":"Myeloproliferative Neoplasms","Cause(s)/pathophysiology":"JAK2 mutation","Symptoms/signs":"Increased RBC mass (Hct), Itching after hot shower (aquagenic pruritus)"}},{"name":"Essential Thrombocytopenia","attributes":{"Class":"Myeloproliferative Neoplasms","Cause(s)/pathophysiology":"JAK2 mutation","Symptoms/signs":"Platelets >600k, thrombosis or bleeding"}},{"name":"Primary myelofibrosis","attributes":{"Class":"Myeloproliferative Neoplasms","Cause(s)/pathophysiology":"JAK2 mutation","Morphological changes":"Teardrop cells (Dacrocytes)","Symptoms/signs":"Dry tap (fibrosis), massive splenomegaly"}},{"name":"Letter-Siwe Disease","attributes":{"Class":"Langerhans Cell Histiocytosis","Typical Population":"Infants (<2 years)","Symptoms/signs":"Skin rash, cystic skeletal defects, multi-organ involvement","Prognosis":"Fatal without treatment"}},{"name":"Eosinophillic Granuloma","attributes":{"Class":"Langerhans Cell Histiocytosis","Typical Population":"Adolescents","Symptoms/signs":"Pathologic fracture (unifocal bone lesion), Langerhans cells + Eosinophils","Prognosis":"Benign"}},{"name":"Pulmonary LCH","attributes":{"Class":"Langerhans Cell Histiocytosis","Typical Population":"Smokers","Symptoms/signs":"Cystic lung disease","Prognosis":"Regression with smoking cessation"}}],
  "Anemias": [{"name": "Hereditary tyrosinemia", "class": "Heme Metabolism", "attributes": {"Mechanism": "ALA dehydratase is competitively inhibited by succinyl acetone (produced by these pts)", "Symptoms": "resembles acute intermittent porphyria\n\npts will excrete excessive amount of ALA in urine"}}, {"name": "Acute Intermittent Porphyria", "class": "Heme Metabolism", "attributes": {"Mechanism": "Defect in PBG deaminase", "Symptoms": "abdominal pain, hypertension, motor system neuropathy, psychosis\n\ndecreased heme levels, upregulated ALAS1\nALA and PBG accumulate", "Treatment": "hematin infusions, high carbohydrate food"}}, {"name": "Congenital Erythropoeitic Porphyria", "class": "Heme Metabolism", "attributes": {"Mechanism": "uroporphyrinogen III synthase is deficient or absent", "Symptoms": "red urine, fluorescent reddish/brown teeth\nphotosensitive skin causes ulceration and disfiguring scars\nanemia\nincreased hair growth\n\nuroporphyrinogen I and coproporphyrinogen accumulate", "Treatment": "hematin infusions, high carbohydrate food"}}, {"name": "Porphyria Cutanea Tarda", "class": "Heme Metabolism", "attributes": {"Mechanism": "urophoryrinogen decarboxylase deficiency", "Symptoms": "photosensitive\n\nuroporphyrins I and III elevated in urine", "Treatment": "hematin infusions, high carbohydrate food"}}, {"name": "Hereditary Coproporphyria", "class": "Heme Metabolism", "attributes": {"Mechanism": "coproporphyrinogen oxidase deficiency", "Symptoms": "photosensitive\n\ncoproporphyrinoogen III accumulate in urine", "Treatment": "hematin infusions, high carbohydrate food"}}, {"name": "Variegate Porphyria", "class": "Heme Metabolism", "attributes": {"Mechanism": "proroporphyrinogen oxidase deficiency", "Symptoms": "photosensitive\n\nprotoporphyrinogen IX accumulate in urine", "Treatment": "hematin infusions, high carbohydrate food"}}, {"name": "Erythropoietic Protoporphyria", "class": "Heme Metabolism", "attributes": {"Mechanism": "ferrochelatase defiency", "Symptoms": "photosensitive\n\nprotoporphyrin accumulates in RBCs, bone marrow, and plasma", "Treatment": "hematin infusions, high carbohydrate food"}}, {"name": "Crigler-Najjar Syndrome Type I", "class": "Bilirubin Metabolism", "attributes": {"Mechanism": "complete absence of UGT1A1 gene", "Symptoms": "severe hyperbilirubinemia --> kernicterus", "Treatment": "Liver transplant\n\nNOT responsive to phenobarbital"}}, {"name": "Criggler-Najjar Syndrome Type II", "class": "Bilirubin Metabolism", "attributes": {"Mechanism": "Partial UGT1A1 deficiency", "Symptoms": "benign, some jaundice", "Treatment": "phenobarbital"}}, {"name": "Gilbert Syndrome", "class": "Bilirubin Metabolism", "attributes": {"Mechanism": "Decreased UDPGT activity", "Symptoms": "benign, occasional bouts of jaundice during stress", "Treatment": "phenobarbital"}}, {"name": "Dubin-Johnson Syndrome", "class": "Bilirubin Metabolism", "attributes": {"Mechanism": "MRP2 or cMOAT mutation\nautosomal recessive", "Symptoms": "grey-black liver\nbenign\nincreased type I:type III ratio", "Treatment": "phenobarbital"}}, {"name": "Neonatal Jaundice", "class": "Bilirubin Metabolism", "attributes": {"Mechanism": "low level of ligandin at birth and low hepatic glucuronyl-transferase activity", "Symptoms": "grey-black liver\nbenign\nincreased type I:type III ratio", "Treatment": "phototherapy, exchange transfusion"}}, {"name": "Rotor Syndrome", "class": "Bilirubin Metabolism", "attributes": {"Mechanism": "autosomal recessive", "Symptoms": "elevated direct bilirubin, jaundice in childhood, elevated coproporphyrin\nbenign", "Treatment": "phototherapy, exchange transfusion"}}, {"name": "Malaria", "class": "Hematologic Infections", "attributes": {"Mechanism": "bite from female anopheles mosquito", "Symptoms": "cyclic fever, hemolytic anemia, fatigue", "Labs": "rings in RBCs, gametocytes in smear", "Testing": "CBC, CMP, coags, urinalysis, chest x-ray, thick and thin blood smears", "Complications": "pulmonary hypertension, myocardial wall stress in children", "Treatment": "artemisinin combination therapy, atovoquone-proguanil, chloroquine\n\nProphylaxis before traveling to endemic areas"}}, {"name": "Babesia", "class": "Hematologic Infections", "attributes": {"Mechanism": "tick bite", "Symptoms": "similar to malaria\nsometimes asymptomatic", "Labs": "tetrad formation in blood smear", "Testing": "blood smear", "Complications": "severe, possibly fatal disease in immunocomprimised/asplenic pts", "Treatment": "azithromycin plus atovaquone\n\navoid tick contact"}}, {"name": "Bartonelloses", "class": "Hematologic Infections", "attributes": {"Mechanism": "gram negative bacteria from sand flies in Andes mountains", "Symptoms": "severe bacteremia illness: Oroya fever\nindolent eruption of blood filled skin lesions: Verruga peruana", "Labs": "large reduction in Hct", "Testing": "blood smear", "Complications": "high mortality in pregnant women and unborn children", "Treatment": "antibiotics"}}, {"name": "Cold Agglutinin Disease", "class": "Hematologic Infections", "attributes": {"Mechanism": "IgM mediated process of AIHA\ncomplement cascade", "Symptoms": "severe bacteremia illness: Oroya fever\nindolent eruption of blood filled skin lesions: Verruga peruana", "Labs": "large reduction in Hct", "Testing": "blood smear", "Complications": "high mortality in pregnant women and unborn children", "Treatment": "antibiotics"}}, {"name": "Parvovirus B19", "class": "Hematologic Infections", "attributes": {"Mechanism": "cytotoxic to erythroid progenitor cells", "Symptoms": "transient aplastic crisis\neythema infectiosum in children\njoint pain in women", "Labs": "large reduction in Hct", "Testing": "blood smear", "Complications": "high mortality in pregnant women and unborn children", "Treatment": "antibiotics"}}, {"name": "Sickle Cell Disease", "class": "Normocytic Anemia", "attributes": {"Mechanism": "Beta chain variant, SNP\n\ngene carried by 10% of those with African descent", "Symptoms": "small blood vessel occulsion, tissue infarction\nHb 5-12 (chronic compensated hemolytic anemia)\nSickling is worse in hypoxia, dehydration, acidosis\nautosplenectomy", "Labs": "No HbA, >90% HbS\nTarget cells, howell-jolly bodies, cells clearly sickled", "Testing": "Hb electrophoresis, sickledex (trait and disease will be positive)", "Complications": "SO MANY\nincreased risk of infections by encapsulated organisms (autosplenectomy), aplastic crisis from parvovirus B19, avascular necrosis, salmonella osteomyelitis, pulmonary HTN, MI, stroke, retinopathy, priapism, renal papillary necrosis", "Treatment": "Pain meds (opioids) during pain crisis\nTransfusions as needed\nhydroxyurea increases HbF\n\ncures: HSCT, gene editing"}}, {"name": "Hemoglobin C Disease", "class": "Normocytic Anemia", "attributes": {"Mechanism": "B globin chain variant, SNP", "Symptoms": "mild chronic hemolytic anemia", "Labs": "95% HbC\nHbC crystals in peripheral blood", "Testing": "Hb electrophoresis, sickledex (trait and disease will be positive)", "Complications": "Less severe than HbSS sickle cell", "Treatment": "Pain meds (opioids) during pain crisis\nTransfusions as needed\nhydroxyurea increases HbF\n\ncures: HSCT, gene editing"}}, {"name": "Hereditary Spherocytosis", "class": "Normocytic Anemia", "attributes": {"Mechanism": "autosomal dominant\nmutation in membrane skeleton proteins (spectrin or ankyrin)\ncells become spheres", "Symptoms": "variable chronic anemia\nsplenomegaly, jaundice, pigment gallstones", "Labs": "RBCs lack central pallor, Hb 6-10, high reticuloytes\n\nspherocytes, Howell-Jolly bodies", "Testing": "osmotic fragility test", "Complications": "aplastic crisis: parvovirus B19", "Treatment": "splenectomy can improve anemia"}}, {"name": "G6PD Deficiency", "class": "Normocytic Anemia", "attributes": {"Mechanism": "X-linked\nAccumulation of oxygen radicals, lack of glutathione (GSH)", "Symptoms": "transient intravascular hemolysis\ntriggers: infection, drugs (antimalarials, bactrim, aspirin, vit K), fava beans", "Labs": "Heinz bodies, bite cells, spherocytes", "Testing": "fluorescent spot test", "Complications": "aplastic crisis: parvovirus B19", "Treatment": "splenectomy can improve anemia"}}, {"name": "Pyruvate Kinase Deficiency", "class": "Normocytic Anemia", "attributes": {"Mechanism": "deficiency causes depletion of ATP and build up of 2,3-BPG", "Symptoms": "hemolytic anemia in newborn\n\njaundice, gallstones, splenomegaly", "Labs": "Heinz bodies, bite cells, spherocytes", "Testing": "fluorescent spot test", "Complications": "aplastic crisis: parvovirus B19", "Treatment": "splenectomy can improve anemia"}}, {"name": "Paroxysmal Nocturnal Hemoglobinuria", "class": "Normocytic Anemia", "attributes": {"Mechanism": "acquired mutations in PIG-A gene (essential for synthesis of GPI anchor proteins) on X chromosome\n\nCD55 and CD59 absent, making cells sensitive to complement mediated lysis", "Symptoms": "episodic hemoglobinuria (red/brown urine, usually in AM), chronic hemolysis, hemosiderinuria\n\nthrombosis is main cause of death", "Labs": "Heinz bodies, bite cells, spherocytes", "Testing": "fluorescent spot test", "Complications": "can transform into AML or MDS", "Treatment": "Eculizumab (blocks C5)"}}, {"name": "Autoimmune Hemolytic Anemia", "class": "Normocytic Anemia", "attributes": {"Mechanism": "antibodies against RBCs (type II hypersensitivity)\n\ncan be warm (IgG) or cold (IgM)", "Symptoms": "episodic hemoglobinuria (red/brown urine, usually in AM), chronic hemolysis, hemosiderinuria\n\nthrombosis is main cause of death", "Labs": "Heinz bodies, bite cells, spherocytes", "Testing": "Coombs test (direct and indirect)", "Complications": "can transform into AML or MDS", "Treatment": "Eculizumab (blocks C5)"}}, {"name": "Iron Deficiency Anemia", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "1. Dietary lack (infants, elderly, poor)\n2. Impaired absorption (celiac, gastrectomy, chronic diarrhea)\n3. Increased requirement (children, pregnancy)\n4. Chronic blood loss (heavy menses, peptic ulcer, colon cancer, hookworm)", "Symptoms": "fatigue, tachycardia, palpitations\n\nsevere: pica (eating dirt), koilonychia (spoon nails), angular cheilosis", "Labs": "Low iron, high TIBC, low ferritin", "Testing": "Prussian blue stain of marrow", "Complications": "can transform into AML or MDS", "Treatment": "oral iron (ferrous sulfate), parenteral iron"}}, {"name": "Anemia of Chronic Disease", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "Chronic inflammation (IL-6) increases Hepcidin\n\nHepcidin locks iron in macrophages (high ferritin) and inhibits absorption", "Symptoms": "fatigue, tachycardia, palpitations\n\nsevere: pica (eating dirt), koilonychia (spoon nails), angular cheilosis", "Labs": "Low iron, low TIBC, HIGH ferritin", "Testing": "Prussian blue stain of marrow", "Complications": "can transform into AML or MDS", "Treatment": "treat underlying cause, EPO"}}, {"name": "Sideroblastic Anemia", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "Defective protoporphyrin synthesis\nIron accumulates in mitochondria", "Symptoms": "fatigue, tachycardia, palpitations\n\nsevere: pica (eating dirt), koilonychia (spoon nails), angular cheilosis", "Labs": "High iron, low TIBC, high ferritin", "Testing": "Ringed Sideroblasts in marrow", "Complications": "can transform into AML or MDS", "Treatment": "pyridoxine (B6) for hereditary form"}}, {"name": "Lead Poisoning", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "Inhibits ferrochelatase and ALA dehydratase", "Symptoms": "Lead lines on gums/bones, Encephalopathy, Abdominal pain, Drop (wrist/foot)", "Labs": "High iron, low TIBC, high ferritin", "Testing": "Basophilic stippling", "Complications": "can transform into AML or MDS", "Treatment": "Dimercaprol, EDTA, Succimer"}}, {"name": "Alpha Thalassemia", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "Gene deletion of alpha globin (chromosome 16)\n\n1 deletion: Silent\n2 deletions: Trait (cis-Asians, trans-Africans)\n3 deletions: HbH disease\n4 deletions: Hb Barts (Hydrops fetalis)", "Symptoms": "variable severity\nHbH: severe hemolytic anemia\nHb Barts: lethal in utero", "Labs": "High iron, low TIBC, high ferritin", "Testing": "Hb electrophoresis", "Complications": "can transform into AML or MDS", "Treatment": "Dimercaprol, EDTA, Succimer"}}, {"name": "Beta Thalassemia Minor", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "Point mutation in beta globin (chromosome 11)\n\nHeterozygote", "Symptoms": "usually asymptomatic", "Labs": "Increased HbA2 (>3.5%)", "Testing": "Hb electrophoresis", "Complications": "can transform into AML or MDS", "Treatment": "Dimercaprol, EDTA, Succimer"}}, {"name": "Beta Thalassemia Major", "class": "Microcytic Anemias\n(MCV<80)", "attributes": {"Mechanism": "Point mutation in beta globin (chromosome 11)\n\nHomozygote (Bo/Bo)", "Symptoms": "severe anemia 6-9 months after birth (as HbF declines)\nChipmunk facies, crewcut skull on xray (marrow expansion)", "Labs": "Increased HbA2 and HbF", "Testing": "Hb electrophoresis", "Complications": "can transform into AML or MDS", "Treatment": "Transfusions (risk of iron overload - hemochromatosis)"}}, {"name": "Folate Deficiency", "class": "Macrocytic Anemias\n(MCV>100)", "attributes": {"Mechanism": "Malnutrition (alcoholics, poor diet), drugs (methotrexate, trimethoprim, phenytoin), increased requirement (pregnancy, cancer)", "Symptoms": "Glossitis", "Labs": "Increased homocysteine, NORMAL methylmalonic acid", "Testing": "Hb electrophoresis", "Complications": "Neural tube defects in fetus", "Treatment": "Folate supplement"}}, {"name": "Vitamin B12 Deficiency", "class": "Macrocytic Anemias\n(MCV>100)", "attributes": {"Mechanism": "Pernicious anemia (anti-IF antibodies), vegan diet, malabsorption (Crohn's), Diphyllobothrium latum (tapeworm)", "Symptoms": "Glossitis\nSubacute combined degeneration (neuropathy)", "Labs": "Increased homocysteine, INCREASED methylmalonic acid", "Testing": "Schilling test (historic)", "Complications": "Neural tube defects in fetus", "Treatment": "B12 injections"}}], "Clotting Disorders": [{"name": "Factor V Mutation/Leiden Mutation", "class": "Inherited Hypercoagulable States", "attributes": {"Mechanism": "mutated form of factor V lacks cleavage site for deactivation by protein C and S\n\nabout 2-15% of caucasians", "Symptoms": "DVT/PE at young age", "Testing": "activated protein C resistance\nV Leiden assay", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest"}}, {"name": "Prothrombin 20210A", "class": "Inherited Hypercoagulable States", "attributes": {"Mechanism": "point mutation in prothrombin -> increased gene expression\nincreased thrombin is produced\n\n1-2% of population", "Symptoms": "DVT/PE at young age", "Testing": "activated protein C resistance\nV Leiden assay", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest"}}, {"name": "Protein C/S Deficiency", "class": "Inherited Hypercoagulable States", "attributes": {"Mechanism": "warfarin causes increased deficiency -> will have procoagulant effect", "Symptoms": "Warfarin induced skin necrosis", "Testing": "activated protein C resistance\nV Leiden assay", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest"}}, {"name": "Antithrombin III Deficiency", "class": "Inherited Hypercoagulable States", "attributes": {"Mechanism": "antithrombin III normally inactivates thrombin and coag factors, deficiency prevents breakdown", "Symptoms": "anticoagulation not achieved with heparin (give coumadin instead!)\nincreased thrombosis risk (young adult onset)", "Testing": "autosomal dominant", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest"}}, {"name": "Heparin Induced Thrombocytopenia (HIT)", "class": "Acquired Hypercoagulable States", "attributes": {"Mechanism": "induces antibodies to complexes of heparin and platelet factor 4 on the surface of platelets\noccurs in 1-5% of pts", "Symptoms": "thrombocytopenia", "Testing": "no good test", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest", "Treatment": "using LMWH has lower risk"}}, {"name": "Preganancy & Oral Contraceptives", "class": "Acquired Hypercoagulable States", "attributes": {"Mechanism": "increased synthesis of blood coagulation factors by liver", "Symptoms": "thrombocytopenia", "Testing": "no good test", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest", "Treatment": "using LMWH has lower risk"}}, {"name": "Migratory Thrombophlebitis (Trousseau Syndrome)", "class": "Acquired Hypercoagulable States", "attributes": {"Mechanism": "disseminated adenocarcinoma", "Symptoms": "thrombocytopenia", "Testing": "no good test", "Labs": "PTT normal, does not change iwth protein C added", "Complications": "Homozygotes: 50x risk of thrombosis (PE/DVT most often)\nHeterozygous: 5x risk\n\nworse with pregnancy, long flights, bed rest", "Treatment": "using LMWH has lower risk"}}, {"name": "Antiphospholipid Antibody Syndrome", "class": "Acquired Hypercoagulable States", "attributes": {"Mechanism": "auto-antibodies induce a hypercoagulable state mediated by binding to epitopes on prothrombin, activating platelets and endothelial injury\n\nprimary form: no autoimmune disease, assoc. with certain drugs/infections\nsecondary form: associated with lupus", "Symptoms": "recurrent thrombosis, repeated miscarriages, cardiac valve vegetations, thrombocytopenia, PE, bowel infarction, renovascular hypertension", "Testing": "no good test", "Labs": "often causes false positives on syphilis tests\n\nprolonged PTT (not resolved on mixing study, also weird bc pt is hypercoagulable)", "Complications": "aggressive form causes widespread small vessel thrombi and multiorgan failure\nmakes surgical procedures more difficult", "Treatment": "using LMWH has lower risk"}}, {"name": "Disseminated Intravascular Coagulation (DIC)", "class": "Acquired Hypercoagulable States", "attributes": {"Mechanism": "consumptive coagulopathy, firbin thrombi in small vessels cause circulatory insufficiency, widespread activation of thrombin\n\nseen in obstetric complications, advanced malignancy, shock", "Symptoms": "initial thrombosis, then bleeding\noozing from IV site", "Testing": "no good test", "Labs": "reduced platelets, fibrinogen, FVIII\nmicroangiopathic hemolytic anemia with schistocytes\n\nabnormal PT/PTT, increased d-dimer, increased fibrin split products", "Complications": "ischemia (lungs->ARDS, adrenals->Waterhouse-Friderichsen syndrome)\nhemorrage", "Treatment": "using LMWH has lower risk"}}, {"name": "Pulmonary Embolism (PE)", "class": "Embolism", "attributes": {"Mechanism": "from thromboemboli from deep saphenous veins, periprostatic venous plexus, uterine venous plexus, right atrium\n\nrisk factors: immobility, hereditary states, oral contraceptives, neoplasms", "Symptoms": "60-80% are silent\n\nsudden onset of chest pain, dyspnea, cough, maybe hemoptysis, tachycardia, hypoxia", "Testing": "H&P, blood gas, V/Q scan, pulmonary angiography, lower extremity doppler (detects DVT)", "Labs": "elevated D-dimer, arterial pO2 <80%, V/Q mismatch\n\nHampton hump on x-ray", "Complications": "sudden death (saddle embolus), pulmonary infarct, pulmonary HTN, recurrence", "Treatment": "using LMWH has lower risk"}}, {"name": "Deep Venous Thrombosis", "class": "Embolism", "attributes": {"Mechanism": "occur in popliteal, femoral, iliac veins, associated with stasis and hypercoagulable states\n\nrisk factors: immobilization, CHF, pregnancy, tumors", "Symptoms": "asymptomatic in 50% of cases", "Testing": "H&P, blood gas, V/Q scan, pulmonary angiography, lower extremity doppler (detects DVT)", "Labs": "elevated D-dimer, arterial pO2 <80%, V/Q mismatch\n\nHampton hump on x-ray", "Complications": "can embolize to lungs and cause a PE", "Treatment": "using LMWH has lower risk"}}, {"name": "Systemic Thromboembolism", "class": "Embolism", "attributes": {"Mechanism": "arterial emboli, 80% from left heart (infarct, fibrillation, left atrial dilation)\n\nparadoxical emboli: emboli gaining access to systemic circulation through heart defects", "Symptoms": "asymptomatic in 50% of cases", "Testing": "H&P, blood gas, V/Q scan, pulmonary angiography, lower extremity doppler (detects DVT)", "Labs": "elevated D-dimer, arterial pO2 <80%, V/Q mismatch\n\nHampton hump on x-ray", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "using LMWH has lower risk"}}, {"name": "Red (Hemorrhagic) Infarct", "class": "Infarction", "attributes": {"Mechanism": "venous occlusions (ovary), loose tissues (lung), dual circulations (lung+small intestine), sluggish venous outflow, blood flow re-established to site of previous arterial occlusion and necrosis", "Symptoms": "asymptomatic in 50% of cases", "Testing": "H&P, blood gas, V/Q scan, pulmonary angiography, lower extremity doppler (detects DVT)", "Labs": "ischemic coagulative necrosis, EXCEPT in brain/CNS (liquefactive)\n\nRED IS DEAD\n\nseptic infarctions: infarct converts to abscess by superimposed infection", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "using LMWH has lower risk"}}, {"name": "White (anemic) Infarct", "class": "Infarction", "attributes": {"Mechanism": "occur in organs with single blood supply, arterial occlusions in solid organs with end-organ arterial circulation (heart, spleen, kidney)", "Symptoms": "asymptomatic in 50% of cases", "Testing": "H&P, blood gas, V/Q scan, pulmonary angiography, lower extremity doppler (detects DVT)", "Labs": "ischemic coagulative necrosis, EXCEPT in brain/CNS (liquefactive)\n\nRED IS DEAD\n\nseptic infarctions: infarct converts to abscess by superimposed infection", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "using LMWH has lower risk"}}, {"name": "Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease)", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "autosomal dominant: mutations in 2 TGF-b binding proteins, including the endothelial protein endoglin", "Symptoms": "localized dilation and convolution of venules and capillaries\nepistaxis, GI bleeding", "Testing": "H&P, blood gas, V/Q scan, pulmonary angiography, lower extremity doppler (detects DVT)", "Labs": "ischemic coagulative necrosis, EXCEPT in brain/CNS (liquefactive)\n\nRED IS DEAD\n\nseptic infarctions: infarct converts to abscess by superimposed infection", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "using LMWH has lower risk"}}, {"name": "Immune Thrombocytopenia Purpura (ITP)", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "usually autoimmune (antibody-mediated) binding to platelets\n\nchildren: follows viral infection/immunization, self-limited\nadults: chronic", "Symptoms": "localized dilation and convolution of venules and capillaries\nepistaxis, GI bleeding", "Testing": "can test antibodies to platelets, not very reliable", "Labs": "thrombocytopenia, normal or increased megakaryocytes, no splenomegaly", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "using LMWH has lower risk"}}, {"name": "Evans Syndrome", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "autoimmune hemolytic anemia+ITP (simultaneously or sequentially)", "Symptoms": "localized dilation and convolution of venules and capillaries\nepistaxis, GI bleeding", "Testing": "can test antibodies to platelets, not very reliable", "Labs": "thrombocytopenia, normal or increased megakaryocytes, no splenomegaly", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "using LMWH has lower risk"}}, {"name": "Thrombotic Thrombocytopenic Purpura (TTP)", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "deficiency in enzyme ADAMTS13 (vWF metalloprotease) due to autoantibodies (more common) or mutation (rare)\n\nvWF multimers are degraded", "Symptoms": "thrombocytopenia, changing neuro signs, renal insufficiency, fever, hyaline microaggregates of platelets in small vessels", "Testing": "can test antibodies to platelets, not very reliable", "Labs": "thrombocytopenia, microangiopathic hemolytic anemia, helmet cells/schistocytes\n\nPT/PTT normal", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "plasma exchange works in 80% of cases"}}, {"name": "Hemolytic-Uremic Syndrome", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "associated with enteric infections with Shiga toxin-producing bacteria such as E coli 0157:H7", "Symptoms": "thrombocytopenia, changing neuro signs, renal insufficiency, fever, hyaline microaggregates of platelets in small vessels", "Testing": "can test antibodies to platelets, not very reliable", "Labs": "thrombocytopenia, microangiopathic hemolytic anemia, helmet cells/schistocytes\n\nPT/PTT normal", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "plasma exchange works in 80% of cases"}}, {"name": "Bernard-Soulier Syndrome", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "autosomal recessive abnormality of GPIb-IX (plays role in adhering platelets to sites of blood vessel injury and in platelet aggregation)", "Symptoms": "thrombocytopenia, changing neuro signs, renal insufficiency, fever, hyaline microaggregates of platelets in small vessels", "Testing": "decreased ristocetin aggregation study (abnormal)", "Labs": "GIANT platelets", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "plasma exchange works in 80% of cases"}}, {"name": "Glanzmann Thrombasthemia", "class": "Disorders of Primary Hemostasis\n\nDefects: at the vascular level, involving platelets, involving vWF", "attributes": {"Mechanism": "deficiency of GPIIb-IIIa\n\nprimary secretion defects are rare\nacquired defects: aspirin-induced acetylation and inactivation of COX, chronic liver disease, uremia", "Symptoms": "thrombocytopenia, changing neuro signs, renal insufficiency, fever, hyaline microaggregates of platelets in small vessels", "Testing": "decreased ristocetin aggregation study (abnormal)", "Labs": "normal platelet morphology, no platelet aggregation, ristocetin normal", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "plasma exchange works in 80% of cases"}}, {"name": "Hemophilia A", "class": "Disorders of Secondary Hemostasis\n\nDeficiency of clotting factors", "attributes": {"Mechanism": "factor VIII deficiency\n\n1/5000-10000 males (x-linked)\nvaries in severity", "Symptoms": "easy bruising, massvie hemorrhage after trauma or surgery, spontaneous hemorrhages into joints (hemarthroses), petechiae absent", "Testing": "FVIII assay via PCR", "Labs": "prolonged aPTT (corrected in mixing study)\nnormal PT, normal platelet count, normal fibrinogen/thrombin time", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "recombinant factor VIII"}}, {"name": "Hemophilia B (Christmas Disease)", "class": "Disorders of Secondary Hemostasis\n\nDeficiency of clotting factors", "attributes": {"Mechanism": "factor IX deficiency\n\nless incidence than A, but clinically indistiguishable", "Symptoms": "easy bruising, massvie hemorrhage after trauma or surgery, spontaneous hemorrhages into joints (hemarthroses), petechiae absent", "Testing": "FIX assay", "Labs": "prolonged aPTT (corrected in mixing study)\nnormal PT, normal platelet count, normal fibrinogen/thrombin time", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "recombinant factor FIX"}}, {"name": "von Willebrand Disease", "class": "Disorders of Secondary Hemostasis\n\nDeficiency of clotting factors", "attributes": {"Mechanism": "quantitative (type I) or qualitative (type II) defects of vWF\nautosomal inheritance (1% of adults)", "Symptoms": "majority have mild disease\nmucocutaneous bleeding, menorrhagia, post surgical bleeding", "Testing": "factor VIII, vWF antigen assay, vWF activity measurements\n\nmultimer analysis (gel electrophoresis)", "Labs": "prolonged aPTT \nnormal PT, normal platelet count, normal fibrinogen/thrombin time", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "recombinant factor FIX"}}, {"name": "Coagulopathy of Liver Disease", "class": "Disorders of Secondary Hemostasis\n\nDeficiency of clotting factors", "attributes": {"Mechanism": "coags all synthesized in liver (except vWF)", "Symptoms": "early change: prolonged PT d/t FVII\nlate change: prolonged aPTT d/t decreased fibrinogen", "Testing": "factor VIII, vWF antigen assay, vWF activity measurements\n\nmultimer analysis (gel electrophoresis)", "Labs": "platelet functional defects common, thrombocytopenia less common", "Complications": "emboli travel to lower extremitis (75%), brain, intestines, spleen, kidneys and cause infarction", "Treatment": "factors II, VII, IX, X may respond to vitamin K"}}], "Anti-Infectives": [{"name": "Penicillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "narrow spectrum, gram positive (strep)", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Amoxicillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "broad spectrum, gram positive (strep), some gram negatives (E. coli, H. influenzae)", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Ampicillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "Listeria, enterococcus", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Nafcillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "penicillinase-resistant, good for MSSA", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Oxacillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "penicillinase-resistant, good for MSSA", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Dicloxacillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "penicillinase-resistant, good for MSSA", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Piperacillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "extended spectrum, works for pseudomonas", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Ticarcillin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "extended spectrum, works for pseudomonas", "Adverse Reactions": "allergies", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Cephalexin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "gram positives, proteus, E. coli, Klebsiella (PEcK)", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Cefazolin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "surgical prophylaxis", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Cefoxitin", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "H. influenzae, enterobacter, neisseria, serratia, proteus, E. coli, klebsiella (HENS PEcK)\n\nanaerobes in the abdomen", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Cefuroxime", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "respiratory infections", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Ceftriaxone", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "meningitis, gonorrhea, disseminated Lyme disease", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Cefotaxime", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "meningitis, gonorrhea, disseminated Lyme disease", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Ceftazidime", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "Pseudomonas", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Cefepime", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "pseudomonas, gram positive", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Ceftaroline", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "MRSA, broad gram negative", "Adverse Reactions": "hypersensitivity\n\n10% of pts with penicillin allergies will be allergic to these", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "used in conjunction with beta lactamase inhibitors (tazobactam, cavulanate)"}}, {"name": "Imipenem", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "broad spectrum, life threatening infections, aerobic and anaerobic", "Adverse Reactions": "seizures, GI distress, skin rash", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Meropenem", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "broad spectrum, life threatening infections, aerobic and anaerobic", "Adverse Reactions": "lower seizure risk", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Ertapenem", "class": "Beta-lactams", "attributes": {"Mechanism of action": "binds transpeptides, prevent crosslinking and weaken cell wall, osmotic pressure causes cells to burst", "Use": "limited pseudomonas coverage", "Adverse Reactions": "seizures, GI distress, skin rash", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Aztreonam", "class": "Beta-lactams", "attributes": {"Mechanism of action": "prevents peptidoglycan crosslinking by binding to PBP3", "Use": "gram negative rods ONLY\n\ngood for pts with penicillin allergy", "Adverse Reactions": "occasional GI upset", "Mechanism of resistance": "mutations encoding transpeptidases (mec2)\n\nbeta-lactamases\n\naltered uptake esp. gram negs. ", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Vancomycin", "class": "Glycopeptides", "attributes": {"Mechanism of action": "Inhibits cell wall synthesis by binding D-ala D-ala portion of cell wall precursors", "Use": "gram positive only, reserved for resistant infections (MRSA)\n\ngiven orally for C. diff", "Adverse Reactions": "Red man syndrome (flushing due to histamine release), Ototoxicity, Nephrotoxicity\n\nthrombophlebitis", "Mechanism of resistance": "change in binding site to D-ala D-lac", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Gentamicin", "class": "Aminoglycosides", "attributes": {"Mechanism of action": "block protein synthesis by binding to 30S subunit", "Use": "severe gram negative rod infections", "Adverse Reactions": "neuromuscular blockade, nephrotoxicity, ototoxicity\n\nstreptomycin is rarely used today due to ototoxicity, is still used for bioterrorism agents", "Mechanism of resistance": "transferase enzymes that inactivate drug", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Tobramycin", "class": "Aminoglycosides", "attributes": {"Mechanism of action": "block protein synthesis by binding to 30S subunit", "Use": "broad spectrum, mostly gram negatives\n\noften given in combination (e.g. beta-lactams) for nosocomial or polymicrobial infections", "Adverse Reactions": "neuromuscular blockade, nephrotoxicity, ototoxicity\n\nstreptomycin is rarely used today due to ototoxicity, is still used for bioterrorism agents", "Mechanism of resistance": "transferase enzymes that inactivate drug", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Neomycin", "class": "Aminoglycosides", "attributes": {"Mechanism of action": "block protein synthesis by binding to 30S subunit", "Use": "bowel surgery prep", "Adverse Reactions": "neuromuscular blockade, nephrotoxicity, ototoxicity\n\nstreptomycin is rarely used today due to ototoxicity, is still used for bioterrorism agents", "Mechanism of resistance": "transferase enzymes that inactivate drug", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Amikacin", "class": "Aminoglycosides", "attributes": {"Mechanism of action": "block protein synthesis by binding to 30S subunit", "Use": "reserved for resistant infections", "Adverse Reactions": "neuromuscular blockade, nephrotoxicity, ototoxicity\n\nstreptomycin is rarely used today due to ototoxicity, is still used for bioterrorism agents", "Mechanism of resistance": "transferase enzymes that inactivate drug", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Streptomycin", "class": "Aminoglycosides", "attributes": {"Mechanism of action": "block protein synthesis by binding to 30S subunit", "Use": "Tuberculosis, bioterrorism", "Adverse Reactions": "neuromuscular blockade, nephrotoxicity, ototoxicity\n\nstreptomycin is rarely used today due to ototoxicity, is still used for bioterrorism agents", "Mechanism of resistance": "transferase enzymes that inactivate drug", "Other things to know": "given with cilastatin to inhibit renal dehydropeptidase I"}}, {"name": "Doxycycline", "class": "Tetracyclines", "attributes": {"Mechanism of action": "binds 30S subunit and prevents attachment of aminoacyl-tRNA", "Use": "Chlamydia, Lyme disease, RMSF\n\naccumulate intracellularly so they work against rickettsia and chlamydia", "Adverse Reactions": "teeth discoloration and inhibition of bone growth in children, photosensitivity\n\ncontraindicated in pregnancy", "Mechanism of resistance": "transport pumps\n\nplasmid encoded", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Minocycline", "class": "Tetracyclines", "attributes": {"Mechanism of action": "binds 30S subunit and prevents attachment of aminoacyl-tRNA", "Use": "Acne", "Adverse Reactions": "teeth discoloration and inhibition of bone growth in children, photosensitivity\n\ncontraindicated in pregnancy", "Mechanism of resistance": "transport pumps\n\nplasmid encoded", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Tetracycline", "class": "Tetracyclines", "attributes": {"Mechanism of action": "binds 30S subunit and prevents attachment of aminoacyl-tRNA", "Use": "Acne", "Adverse Reactions": "teeth discoloration and inhibition of bone growth in children, photosensitivity\n\ncontraindicated in pregnancy", "Mechanism of resistance": "transport pumps\n\nplasmid encoded", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Azithromycin", "class": "Macrolides", "attributes": {"Mechanism of action": "binds 23S rRNA of 50S subunit", "Use": "atypical pneumonias (Mycoplasma, Chlamydia, Legionella), STDs (Chlamydia)", "Adverse Reactions": "GI motility issues, arrhythmia (long QT), cholestatic hepatitis", "Mechanism of resistance": "methylation of 23S rRNA binding site", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Clarithromycin", "class": "Macrolides", "attributes": {"Mechanism of action": "binds 23S rRNA of 50S subunit", "Use": "H. pylori", "Adverse Reactions": "GI motility issues, arrhythmia (long QT), cholestatic hepatitis", "Mechanism of resistance": "methylation of 23S rRNA binding site", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Erythromycin", "class": "Macrolides", "attributes": {"Mechanism of action": "binds 23S rRNA of 50S subunit", "Use": "atypical pneumonias (Mycoplasma, Chlamydia, Legionella), STDs (Chlamydia)", "Adverse Reactions": "GI motility issues, arrhythmia (long QT), cholestatic hepatitis", "Mechanism of resistance": "methylation of 23S rRNA binding site", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Clindamycin", "class": "Lincosamides", "attributes": {"Mechanism of action": "binds 50S subunit", "Use": "anaerobic infections (above diaphragm)", "Adverse Reactions": "C. diff colitis", "Mechanism of resistance": "methylation of 23S rRNA binding site", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Linezolid", "class": "Oxazolidinones", "attributes": {"Mechanism of action": "binds 50S subunit", "Use": "VRE, MRSA", "Adverse Reactions": "bone marrow suppression, peripheral neuropathy, serotonin syndrome", "Mechanism of resistance": "point mutation of rRNA", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Chloramphenicol", "class": "Oxazolidinones", "attributes": {"Mechanism of action": "binds 50S subunit", "Use": "Meningitis (H. flu, Neisseria, Strep pneumo)\n\nlargely replaced by Ceftriaxone", "Adverse Reactions": "anemia, aplastic anemia, gray baby syndrome (preemies lack liver UDP-glucuronyl transferase)", "Mechanism of resistance": "plasmid encoded acetyltransferase", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Trimethoprim-Sulfamethoxazole", "class": "Sulfonamides", "attributes": {"Mechanism of action": "SMX: PABA antimetabolite inhibits dihydropteroate synthase\nTMP: inhibits dihydrofolate reductase", "Use": "UTIs, PCP, Shigella, Salmonella, Toxoplasmosis", "Adverse Reactions": "hypersensitivity, hemolysis if G6PD deficient, nephrotoxicity, photosensitivity, kernicterus in infants", "Mechanism of resistance": "altered enzyme, decreased uptake, increased PABA synthesis", "Other things to know": "Do NOT take with milk, antacids, or iron containing preparations"}}, {"name": "Ciprofloxacin", "class": "Fluoroquinolones", "attributes": {"Mechanism of action": "inhibits DNA gyrase (topoisomerase II) and topoisomerase IV", "Use": "gram negative rods of urinary and GI tracts, pseudomonas", "Adverse Reactions": "GI upset, superinfections, skin rashes, tendonitis/tendon rupture", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "contraindicated in pregnancy, nursing mothers, and children <18 (damage to cartilage)\n\ninteraction with antacids"}}, {"name": "Levofloxacin", "class": "Fluoroquinolones", "attributes": {"Mechanism of action": "inhibits DNA gyrase (topoisomerase II) and topoisomerase IV", "Use": "Respiratory infections", "Adverse Reactions": "GI upset, superinfections, skin rashes, tendonitis/tendon rupture", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "contraindicated in pregnancy, nursing mothers, and children <18 (damage to cartilage)\n\ninteraction with antacids"}}, {"name": "Moxifloxacin", "class": "Fluoroquinolones", "attributes": {"Mechanism of action": "inhibits DNA gyrase (topoisomerase II) and topoisomerase IV", "Use": "Respiratory infections", "Adverse Reactions": "GI upset, superinfections, skin rashes, tendonitis/tendon rupture", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "contraindicated in pregnancy, nursing mothers, and children <18 (damage to cartilage)\n\ninteraction with antacids"}}, {"name": "Metronidazole", "class": "Nitroimidazoles", "attributes": {"Mechanism of action": "forms free radicals", "Use": "anaerobes (below diaphragm), protozoa (giardia, entamoeba, trichomonas), H. pylori", "Adverse Reactions": "metallic taste, disulfiram-like reaction with alcohol", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "contraindicated in pregnancy, nursing mothers, and children <18 (damage to cartilage)\n\ninteraction with antacids"}}, {"name": "Daptomycin", "class": "Lipopeptides", "attributes": {"Mechanism of action": "lipopeptide that disrupts cell membrane", "Use": "MRSA skin infections, bacteremia, endocarditis, VRE", "Adverse Reactions": "myopathy, rhabdomyolysis", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "NOT for pneumonia (inactivated by surfactant)"}}, {"name": "Polymyxin B", "class": "Polymyxins", "attributes": {"Mechanism of action": "cationic polypeptide that binds to phospholipids on cell membrane of gram negatives", "Use": "resistant gram negatives", "Adverse Reactions": "neurotoxicity, acute renal tubular necrosis", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "NOT for pneumonia (inactivated by surfactant)"}}, {"name": "Nitrofurantoin", "class": "Nitrofurans", "attributes": {"Mechanism of action": "cationic polypeptide that binds to phospholipids on cell membrane of gram negatives", "Use": "simple UTIs\n\nsafe in pregnancy", "Adverse Reactions": "neurotoxicity, acute renal tubular necrosis", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "NOT for pneumonia (inactivated by surfactant)"}}, {"name": "Isoniazid", "class": "Antimycobacterial", "attributes": {"Mechanism of action": "decreases synthesis of mycolic acids", "Use": "TB", "Adverse Reactions": "neurotoxicity (prevent with B6), hepatotoxicity", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "different drugs have different mechanisms"}}, {"name": "Rifampin", "class": "Antimycobacterial", "attributes": {"Mechanism of action": "inhibits DNA-dependent RNA polymerase", "Use": "TB, delays resistance to dapsone for leprosy, meningococcal prophylaxis", "Adverse Reactions": "orange body fluids, CYP450 inducer", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "different drugs have different mechanisms"}}, {"name": "Pyrazinamide", "class": "Antimycobacterial", "attributes": {"Mechanism of action": "uncertain", "Use": "TB", "Adverse Reactions": "hyperuricemia, hepatotoxicity", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "different drugs have different mechanisms"}}, {"name": "Ethambutol", "class": "Antimycobacterial", "attributes": {"Mechanism of action": "blocks arabinosyltransferase", "Use": "TB", "Adverse Reactions": "optic neuropathy (red-green color blindness)", "Mechanism of resistance": "chromosome encoded mutation in DNA gyrase, efflux pumps", "Other things to know": "different drugs have different mechanisms"}}], "Microbes": [{"name": "Staphylococcus aureus", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "Transient normal flora on skin, vagina, other mucosal surfaces\n\nNasopharynx often colonized", "Transmission": "direct contact or respiratory droplets", "Diseases": "Skin infections: cellulitis, impetigo, folliculitis, carbuncles, scaled skin syndrome\n\nosteomyelitis, septic arthritis, endocarditis, pnemonia, gatroenteritis\n\ntoxic shock, bactermeia", "Risk factors": "implanted devices, IV drug use, intubation", "Pathogenesis factors": "adhesion proteins, MSCRAMMs, toxins", "Identification": "gram stain and culture\n\ncatalase+, coagulase+, beta hemolytic, yallow colonies on mannitol-salt agar", "Treatment": "I&D absesses\n\nMRSA: Vancomycin\n\nMSSA: nafcillin", "Prevention": "Good hygiene"}}, {"name": "Staphylococcus epidermidis", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "Normal skin flora, mucosal surfaces, conjuctiva, ears, vagina", "Transmission": "normal flora by direct contact", "Diseases": "infections due to implanted devices", "Risk factors": "implanted devices", "Pathogenesis factors": "biofilms", "Identification": "gram stain and culture\n", "Treatment": "Vancomycin with rifampin or gentamicin", "Prevention": "Good hygiene"}}, {"name": "Staphylococcus saprophyticus", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci in clusters", "Natural reservoir": "Normal skin flora, mucosal surfaces, conjuctiva, ears, vagina", "Transmission": "normal flora by direct contact", "Diseases": "cystitis in women", "Risk factors": "sexual activity", "Pathogenesis factors": "biofilms", "Identification": "gram stain and culture\n\ncatalase+, coagulase-, novobiocin resistent", "Treatment": "TMP-SMX", "Prevention": "Good hygiene"}}, {"name": "Strepococcus pyogenes (GAS)", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "Transient normal flora on skin, oropharynx", "Transmission": "respiratory droplets or direct contact", "Diseases": "cellulitis, impetigo, erysipelas\n\nscarlet fever, pueperal sepsis, bacteremia, pneumonia, necrotizing fasciitis, TSS, pharyngitis", "Risk factors": "children/elderly, immunocompromised", "Pathogenesis factors": "adhesion proteins, toxins", "Identification": "gram stain and culture\n\ncatalase negative, beta hemolytic, bacitracin sensitive", "Treatment": "Penicillin", "Prevention": "Good hygiene"}}, {"name": "Streptococcus Agalactiae (GBS)", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "normal flora of vagina and GI tract", "Transmission": "mother to newborn during pregnancy, delivery, or later", "Diseases": "meningitis, sepsis in neonates, skin infections esp. in diabetic foot ulcers", "Risk factors": "neonates, diabetes", "Pathogenesis factors": "adhesion proteins, toxins", "Identification": "gram stain and culture\n\ncatalase negative, beta hemolytic, bacitracin resistant, hippurate hydrolysis positive", "Treatment": "penicillin, ampicillin with gentamycin for severe cases", "Prevention": "screening of pregnant women"}}, {"name": "Viridans streptococci", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "normal flora of oropharynx", "Transmission": "endogenous", "Diseases": "subacute endocarditis, dental caries", "Risk factors": "dental procedures", "Pathogenesis factors": "adhesion proteins, toxins", "Identification": "gram stain and culture\n\ncatalase negative, alpha hemolytic, optochin resistant", "Treatment": "penicillin", "Prevention": "prophylactic antibiotics for dental procedures"}}, {"name": "Streptococcus pneumoniae", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "normal flora of nasopharynx", "Transmission": "respiratory droplets", "Diseases": "pneumonia, meningitis, otitis media, sinusitis", "Risk factors": "children/elderly, immunocompromised", "Pathogenesis factors": "capsule, toxins", "Identification": "gram stain and culture\n\ncatalase negative, alpha hemolytic, optochin sensitive", "Treatment": "penicillin, ceftriaxone, vancomycin", "Prevention": "vaccine"}}, {"name": "Enterococcus", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive cocci", "Natural reservoir": "normal flora of GI tract", "Transmission": "endogenous", "Diseases": "UTI, biliary tract infections, subacute endocarditis", "Risk factors": "hospitalization, catheterization", "Pathogenesis factors": "adhesion proteins, toxins", "Identification": "gram stain and culture\n\ncatalase negative, gamma hemolytic", "Treatment": "ampicillin with gentamycin, vancomycin", "Prevention": "Good hygiene"}}, {"name": "Bacillus anthracis", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive rod", "Natural reservoir": "soil, animals", "Transmission": "contact with spores", "Diseases": "anthrax (cutaneous, inhalation, GI)", "Risk factors": "contact with animals", "Pathogenesis factors": "capsule, toxins", "Identification": "gram stain and culture\n\nmedusa head colonies", "Treatment": "ciprofloxacin, doxycycline", "Prevention": "vaccine"}}, {"name": "Bacillus cereus", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive rod", "Natural reservoir": "soil, food", "Transmission": "ingestion of contaminated food", "Diseases": "food poisoning", "Risk factors": "eating reheated rice", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "supportive", "Prevention": "proper food storage"}}, {"name": "Clostridium tetani", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative coccobacillus", "Natural reservoir": "spores in soils", "Transmission": "innoculation via trauma with contaminated soils", "Diseases": "rigid paralysis, often with lockjaw\nstarts with cramping and twitching around wound site then spreads", "Risk factors": "penetrating trauma\nlack of immunization", "Pathogenesis factors": "toxin called tetanospasmin which blocks the release of inhibitory neurotransmitters such as GABA and glycine", "Identification": "clinical picture", "Treatment": "antitoxin sera with penicillin or metronidazole", "Prevention": "DPT vaccine"}}, {"name": "Clostridium botulinum", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative coccobacillus", "Natural reservoir": "spores in soils", "Transmission": "ingestion of contaminated food", "Diseases": "flaccid paralysis", "Risk factors": "improperly canned food", "Pathogenesis factors": "toxin blocks ACh release", "Identification": "clinical picture", "Treatment": "antitoxin", "Prevention": "proper food storage"}}, {"name": "Clostridium perfringens", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative coccobacillus", "Natural reservoir": "spores in soils", "Transmission": "innoculation via trauma with contaminated soils", "Diseases": "gas gangrene", "Risk factors": "penetrating trauma", "Pathogenesis factors": "toxins", "Identification": "clinical picture", "Treatment": "debridement, penicillin", "Prevention": "proper wound care"}}, {"name": "Clostridium difficile", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative coccobacillus", "Natural reservoir": "normal flora of GI tract", "Transmission": "endogenous", "Diseases": "pseudomembranous colitis", "Risk factors": "antibiotic use", "Pathogenesis factors": "toxins", "Identification": "toxin assay", "Treatment": "oral vancomycin, metronidazole", "Prevention": "proper antibiotic use"}}, {"name": "Listeria monocytogenes", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive rod", "Natural reservoir": "soil, animals", "Transmission": "ingestion of contaminated food", "Diseases": "meningitis, sepsis in neonates/immunocompromised", "Risk factors": "neonates/elderly, immunocompromised", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "ampicillin with gentamycin", "Prevention": "proper food storage"}}, {"name": "Actinomyces", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive rod", "Natural reservoir": "normal flora of oral cavity", "Transmission": "endogenous", "Diseases": "abscesses", "Risk factors": "dental procedures", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "penicillin", "Prevention": "good oral hygiene"}}, {"name": "Nocardia", "class": "Bacteria", "attributes": {"Characteristics": "Gram positive rod", "Natural reservoir": "soil", "Transmission": "inhalation", "Diseases": "pneumonia, abscesses", "Risk factors": "immunocompromised", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "TMP-SMX", "Prevention": "avoid soil exposure"}}, {"name": "Neisseria meningitidis", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative diplococci", "Natural reservoir": "normal flora of nasopharynx", "Transmission": "respiratory droplets", "Diseases": "meningitis, sepsis", "Risk factors": "crowded living conditions", "Pathogenesis factors": "capsule, toxins", "Identification": "gram stain and culture", "Treatment": "ceftriaxone", "Prevention": "vaccine"}}, {"name": "Neisseria gonorrhoeae", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative diplococci", "Natural reservoir": "humans", "Transmission": "sexual contact", "Diseases": "gonorrhea", "Risk factors": "sexual activity", "Pathogenesis factors": "adhesion proteins, toxins", "Identification": "gram stain and culture", "Treatment": "ceftriaxone with azithromycin", "Prevention": "safe sex"}}, {"name": "Klebsiella", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative rod", "Natural reservoir": "normal flora of GI tract", "Transmission": "endogenous", "Diseases": "pneumonia, UTI", "Risk factors": "hospitalization, alcoholism", "Pathogenesis factors": "capsule, toxins", "Identification": "gram stain and culture", "Treatment": "cephalosporins", "Prevention": "good hygiene"}}, {"name": "Pseudomonas aeruginosa", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative rod", "Natural reservoir": "water, soil", "Transmission": "contact with contaminated water", "Diseases": "pneumonia, UTI, wound infections", "Risk factors": "hospitalization, cystic fibrosis", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "piperacillin, ceftazidime", "Prevention": "good hygiene"}}, {"name": "E. coli", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative rod", "Natural reservoir": "normal flora of GI tract", "Transmission": "endogenous", "Diseases": "UTI, diarrhea, meningitis", "Risk factors": "hospitalization, catheterization", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "cephalosporins, TMP-SMX", "Prevention": "good hygiene"}}, {"name": "Salmonella", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative rod", "Natural reservoir": "animals", "Transmission": "ingestion of contaminated food", "Diseases": "gastroenteritis, typhoid fever", "Risk factors": "eating raw eggs/poultry", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "supportive, ciprofloxacin", "Prevention": "proper food storage"}}, {"name": "Vibrio cholerae", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative rod", "Natural reservoir": "water", "Transmission": "ingestion of contaminated water", "Diseases": "cholera", "Risk factors": "poor sanitation", "Pathogenesis factors": "toxins", "Identification": "gram stain and culture", "Treatment": "supportive, doxycycline", "Prevention": "proper sanitation"}}, {"name": "Helicobacter pylori", "class": "Bacteria", "attributes": {"Characteristics": "Gram negative rod", "Natural reservoir": "humans", "Transmission": "fecal-oral", "Diseases": "gastritis, peptic ulcers", "Risk factors": "poor sanitation", "Pathogenesis factors": "toxins", "Identification": "breath test, stool antigen", "Treatment": "triple therapy", "Prevention": "good hygiene"}}, {"name": "Borrelia burgdorferi", "class": "Bacteria", "attributes": {"Characteristics": "Spirochete", "Natural reservoir": "animals", "Transmission": "tick bite", "Diseases": "Lyme disease", "Risk factors": "outdoor activities", "Pathogenesis factors": "toxins", "Identification": "serology", "Treatment": "doxycycline", "Prevention": "avoid ticks"}}, {"name": "Treponema pallidum", "class": "Bacteria", "attributes": {"Characteristics": "Spirochete", "Natural reservoir": "humans", "Transmission": "sexual contact", "Diseases": "syphilis", "Risk factors": "sexual activity", "Pathogenesis factors": "toxins", "Identification": "serology", "Treatment": "penicillin", "Prevention": "safe sex"}}, {"name": "Chlamydia trachomatis", "class": "Bacteria", "attributes": {"Characteristics": "Intracellular bacteria", "Natural reservoir": "humans", "Transmission": "sexual contact", "Diseases": "chlamydia", "Risk factors": "sexual activity", "Pathogenesis factors": "toxins", "Identification": "NAAT", "Treatment": "azithromycin, doxycycline", "Prevention": "safe sex"}}, {"name": "Rickettsia rickettsii", "class": "Bacteria", "attributes": {"Characteristics": "Intracellular bacteria", "Natural reservoir": "animals", "Transmission": "tick bite", "Diseases": "RMSF", "Risk factors": "outdoor activities", "Pathogenesis factors": "toxins", "Identification": "serology", "Treatment": "doxycycline", "Prevention": "avoid ticks"}}]};

// --- LOGIC ---
    let activeDeck = Object.keys(db)[0];
    let cardQueue = [];
    let currentItem = null;
    let streak = 0;
    let isFlashcard = false;
    let flaggedItems = new Set();

    function init() {
        try {
            const saved = localStorage.getItem('med_mastermind_flags_v6_3');
            if (saved) flaggedItems = new Set(JSON.parse(saved));
            renderNav();
            prepareDeck(activeDeck);
        } catch (e) {
            alert("Error loading app: " + e.message);
        }
    }

    function prepareDeck(deckName) {
        let items = [];
        
        if (deckName === 'Flagged') {
            flaggedItems.forEach(id => {
                const [d, n] = id.split(':');
                if (db[d]) {
                    const found = db[d].find(i => i.name === n);
                    if (found) items.push(found);
                }
            });
        } else {
            items = [...db[deckName]];
            
            // GENERATE CLASS CARDS
            const groups = {};
            db[deckName].forEach(item => {
                // Try Class, then class (lowercase), then Group
                const cls = item.attributes.Class || item.class || item.attributes.Group;
                if (cls) {
                    if (!groups[cls]) groups[cls] = [];
                    groups[cls].push(item.name);
                }
            });
            
            Object.keys(groups).forEach(cls => {
                if (groups[cls].length > 1) {
                    items.push({
                        isClassCard: true,
                        name: cls, // Answer
                        list: groups[cls], // Clue
                        attributes: { "Card Type": "Classification" }
                    });
                }
            });
        }
        
        cardQueue = shuffleArray(items);
        updateCountDisplay();
        nextQuestion();
    }

    function shuffleArray(array) {
        for (let i = array.length - 1; i > 0; i--) {
            const j = Math.floor(Math.random() * (i + 1));
            [array[i], array[j]] = [array[j], array[i]];
        }
        return array;
    }

    function renderNav() {
        const nav = document.getElementById('nav-container');
        nav.innerHTML = '';
        Object.keys(db).forEach(key => {
            const btn = document.createElement('button');
            btn.className = `nav-btn ${key === activeDeck ? 'active' : ''}`;
            btn.textContent = key;
            btn.onclick = () => switchDeck(key);
            nav.appendChild(btn);
        });
        const flagBtn = document.createElement('button');
        flagBtn.className = `nav-btn flagged-deck ${activeDeck === 'Flagged' ? 'active' : ''}`;
        flagBtn.textContent = `★ Flagged (${flaggedItems.size})`;
        flagBtn.onclick = () => switchDeck('Flagged');
        nav.appendChild(flagBtn);
    }

    function switchDeck(name) {
        if (name === 'Flagged' && flaggedItems.size === 0) return alert("Flag some items first!");
        activeDeck = name;
        streak = 0;
        document.getElementById('deck-indicator').textContent = `Deck: ${name}`;
        document.getElementById('streak-indicator').textContent = `Streak: 0`;
        renderNav();
        prepareDeck(name);
    }

    function toggleMode() {
        isFlashcard = document.getElementById('mode-switch').checked;
        document.getElementById('mode-label').textContent = isFlashcard ? "Mode: Flashcard" : "Mode: Quiz";
        document.getElementById('quiz-area').classList.toggle('hidden', isFlashcard);
        document.getElementById('flashcard-area').classList.toggle('hidden', !isFlashcard);
    }

    function toggleFlag() {
        if (!currentItem || currentItem.isClassCard) return;
        
        let sourceDeck = activeDeck;
        if (activeDeck === 'Flagged') {
            for (const [key, val] of Object.entries(db)) {
                if (val.find(i => i.name === currentItem.name)) sourceDeck = key;
            }
        } else {
             for (const [key, val] of Object.entries(db)) {
                if (val.find(i => i.name === currentItem.name)) sourceDeck = key;
            }
        }
        
        const id = `${sourceDeck}:${currentItem.name}`;
        if (flaggedItems.has(id)) flaggedItems.delete(id);
        else flaggedItems.add(id);
        
        localStorage.setItem('med_mastermind_flags_v6_3', JSON.stringify([...flaggedItems]));
        updateFlagIcon();
        renderNav();
    }

    function updateFlagIcon() {
        const btn = document.getElementById('flag-btn');
        if (currentItem.isClassCard) { btn.style.display = 'none'; return; }
        else { btn.style.display = 'block'; }

        let sourceDeck = null;
        for (const [key, val] of Object.entries(db)) {
            if (val.find(i => i.name === currentItem.name)) { sourceDeck = key; break; }
        }
        const id = `${sourceDeck}:${currentItem.name}`;
        
        if (flaggedItems.has(id)) {
            btn.classList.add('active');
            btn.style.color = '#f38ba8';
        } else {
            btn.classList.remove('active');
            btn.style.color = '#45475a';
        }
    }

    function updateCountDisplay() {
        document.getElementById('remaining-indicator').textContent = `Cards: ${cardQueue.length}`;
    }

    function nextQuestion() {
        document.getElementById('next-btn').classList.add('hidden');
        document.getElementById('flashcard-answer').classList.add('hidden');
        document.getElementById('flashcard-judgement').classList.add('hidden');
        document.getElementById('reveal-btn').classList.remove('hidden');
        document.getElementById('quiz-area').innerHTML = '';

        if (cardQueue.length === 0) {
            prepareDeck(activeDeck);
            return;
        }
        
        currentItem = cardQueue.pop();
        updateCountDisplay();
        updateFlagIcon();

        const container = document.getElementById('vignette-box');
        container.innerHTML = '';

        if (currentItem.isClassCard) {
            // CLASS CARD RENDER
            const title = document.createElement('div');
            title.className = 'class-card-header';
            title.textContent = "Identify the Drug Class / Group";
            container.appendChild(title);

            const ul = document.createElement('ul');
            ul.className = 'drug-list';
            currentItem.list.forEach(item => {
                const li = document.createElement('li');
                li.textContent = item;
                ul.appendChild(li);
            });
            container.appendChild(ul);

        } else {
            // NORMAL CARD RENDER
            const attrs = currentItem.attributes;
            const keys = Object.keys(attrs).filter(k => k !== "Class" && k !== "Group" && k !== "Category" && k !== "Type" && k !== "Subclass");
            
            if (keys.length === 0) {
                const fallbackKey = Object.keys(attrs).find(k => k === "Class" || k === "Group" || k === "Category" || k === "Type");
                if (fallbackKey) {
                    const div = document.createElement('div');
                    div.className = 'vignette-item';
                    div.innerHTML = `<span class="vignette-label">Category Hint</span><span class="vignette-text">${attrs[fallbackKey]}</span>`;
                    container.appendChild(div);
                }
            } else {
                for (let i = keys.length - 1; i > 0; i--) {
                    const j = Math.floor(Math.random() * (i + 1));
                    [keys[i], keys[j]] = [keys[j], keys[i]];
                }
                const selectedKeys = keys.slice(0, Math.min(4, keys.length));
                
                selectedKeys.forEach(key => {
                    const div = document.createElement('div');
                    div.className = 'vignette-item';
                    div.innerHTML = `<span class="vignette-label">${key}</span><span class="vignette-text">${attrs[key]}</span>`;
                    container.appendChild(div);
                });
            }
        }

        if (!isFlashcard) {
            const correct = currentItem.name;
            let options = new Set([correct]);
            let pool = [];

            if (currentItem.isClassCard) {
                const allClasses = new Set();
                db[activeDeck].forEach(i => {
                    const c = i.attributes.Class || i.class || i.attributes.Group;
                    if(c) allClasses.add(c);
                });
                pool = Array.from(allClasses);
            } else {
                // NORMAL CARD DISTRACTORS
                // Smart Filter: Exclude items with same Class/Group
                const currentClass = currentItem.attributes.Class || currentItem.attributes.Group;
                
                pool = db[activeDeck]
                    .filter(i => {
                        const iClass = i.attributes.Class || i.attributes.Group;
                        // Keep if classes are DIFFERENT (or if no class exists)
                        if (currentClass && iClass === currentClass) return false;
                        return true;
                    })
                    .map(i => i.name);
                
                // Fallback if pool is empty (unlikely with this many items)
                if (pool.length < 3) pool = db[activeDeck].map(i => i.name).filter(n => n !== correct);
            }

            let attempts = 0;
            while (options.size < 4 && attempts < 200) {
                const r = pool[Math.floor(Math.random() * pool.length)];
                if (r) options.add(r);
                attempts++;
            }
            
            Array.from(options).sort(() => Math.random() - 0.5).forEach(opt => {
                const btn = document.createElement('button');
                btn.className = 'opt-btn';
                btn.textContent = opt;
                btn.onclick = () => checkQuiz(btn, opt, correct);
                document.getElementById('quiz-area').appendChild(btn);
            });
        }
    }

    function checkQuiz(btn, selected, correct) {
        const btns = document.querySelectorAll('.opt-btn');
        btns.forEach(b => b.disabled = true);
        
        if (selected === correct) {
            btn.classList.add('correct');
            streak++;
        } else {
            btn.classList.add('wrong');
            streak = 0;
            btns.forEach(b => { if(b.textContent === correct) b.classList.add('correct'); });
            
            if (cardQueue.length > 0) {
                 const insertPos = Math.floor(Math.random() * cardQueue.length);
                 cardQueue.splice(insertPos, 0, currentItem);
                 updateCountDisplay();
            } else {
                 cardQueue.push(currentItem);
            }
        }
        document.getElementById('streak-indicator').textContent = `Streak: ${streak}`;
        document.getElementById('next-btn').classList.remove('hidden');
    }

    function revealFlashcard() {
        document.getElementById('reveal-btn').classList.add('hidden');
        const ans = document.getElementById('flashcard-answer');
        ans.textContent = currentItem.name;
        ans.classList.remove('hidden');
        document.getElementById('flashcard-judgement').classList.remove('hidden');
    }

    function rateFlashcard(success) {
        if (success) streak++;
        else {
            streak = 0;
            if(!currentItem.isClassCard) {
                const btn = document.getElementById('flag-btn');
                if (!btn.classList.contains('active')) toggleFlag();
            }
            if (cardQueue.length > 0) {
                 const insertPos = Math.floor(Math.random() * cardQueue.length);
                 cardQueue.splice(insertPos, 0, currentItem);
                 updateCountDisplay();
            } else {
                 cardQueue.push(currentItem);
            }
        }
        document.getElementById('streak-indicator').textContent = `Streak: ${streak}`;
        nextQuestion();
    }

    init();
</script>
</body>
</html>
